AnaptysBio Inc buy Guggenheim
Start price
28.05.25
/
50%
€18.40
Target price
28.05.26
€79.52
Performance (%)
162.93%
End price
29.05.26
€48.38
Summary
This prediction ended on 29.05.26 with a price of €48.38. The BUY prediction by Guggenheim for AnaptysBio Inc saw massive gains of 162.93%. Guggenheim has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -0.716% | -0.716% | 144.249% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by Guggenheim for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) had its price target raised by analysts at Guggenheim from $54.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten